Factors associated with short-term local recurrence of liver cancer after percutaneous ablation using irreversible electroporation: A prospective single-center study

Journal of Vascular and Interventional Radiology

Volumn 26, Issue 5, 2015, Pages 694-702

  Niessen, Christoph ^a   Igl, Juliane ^a   Pregler, Benedikt ^a   Beyer, Lukas ^a   Noeva, Ekaterina ^a   Dollinger, Marco ^a   Schreyer, Andreas G ^a   Jung, Ernst M ^a   Stroszczynski, Christian ^a   Wiggermann, Philipp ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER THERAPY; CHILD PUGH SCORE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; FEMALE; FLUOROSCOPY; FOLLOW UP; HUMAN; IRREVERSIBLE ELECTROPORATION DEVICE; LIVER CANCER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS IRREVERSIBLE ELECTROPORATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME ULTRASOUND SCANNER; RECURRENCE RISK; RECURRENT DISEASE; SHORT TERM LOCAL RECURRENCE; TREATMENT OUTCOME; ADVERSE EFFECTS; DEVICES; ELECTROPORATION; ETIOLOGY; LIVER NEOPLASMS; MIDDLE AGED; TUMOR RECURRENCE;

ABLATION TECHNIQUES; AGED; ELECTROPORATION; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES;

EID: 84928827764     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2015.02.001     Document Type: Article

References (39)

1. J. Bruix, M. Sherman Practice Guidelines Committee American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
2. C.T. Sofocleous, E.N. Petre, and M. Gonen CT-guided radiofrequency ablation as a salvage treatment of colorectal cancer hepatic metastases developing after hepatectomy J Vasc Interv Radiol 22 2011 755 761
3. D.S. Lu, N.C. Yu, and S.S. Raman Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver Radiology 234 2005 954 960
4. E.J. Patterson, C.H. Scudamore, D.A. Owen, A.G. Nagy, and A.K. Buczkowski Radiofrequency ablation of porcine liver in vivo: effects of blood flow and treatment time on lesion size Ann Surg 227 1998 559 565
5. S.W. Kim, H. Rhim, and M. Park Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy Korean J Radiol 10 2009 366 376
6. Y. Komorizono, M. Oketani, and K. Sako Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation Cancer 97 2003 1253 1262
7. R.V. Davalos, I.L. Mir, and B. Rubinsky Tissue ablation with irreversible electroporation Ann Biomed Eng 33 2005 223 231
8. M. Bower, L. Sherwood, Y. Li, and R. Martin Irreversible electroporation of the pancreas: definitive local therapy without systemic effects J Surg Oncol 104 2011 22 28
9. R.C. Lee Cell injury by electric forces Ann N Y Acad Sci 1066 2005 85 91
10. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick, and D.E. Dupuy Irreversible electroporation of the pancreas in swine: a pilot study HPB: the official journal of the International Hepato Pancreato Biliary Association 12 2010 348 351
11. K.P. Charpentier, F. Wolf, L. Noble, B. Winn, M. Resnick, and D.E. Dupuy Irreversible electroporation of the liver and liver hilum in swine HPB: the official journal of the International Hepato Pancreato Biliary Association 13 2011 168 173
12. A. Deodhar, S. Monette, and G.W. Single Jr Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model Urology 77 2011 754 760
13. A. Jose, L. Sobrevals, A. Ivorra, and C. Fillat Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models Cancer Lett 317 2012 16 23
14. G. Onik, P. Mikus, and B. Rubinsky Irreversible electroporation: implications for prostate ablation Technol Cancer Res Treat 6 2007 295 300
15. M.A. Phillips, R. Narayan, T. Padath, and B. Rubinsky Irreversible electroporation on the small intestine Br J Cancer 106 2012 490 495
16. H. Schoellnast, S. Monette, and P.C. Ezell Irreversible electroporation adjacent to the rectum: evaluation of pathological effects in a pig model Cardiovasc Intervent Radiol 36 2013 213 220
17. J.J. Wendler, M. Pech, and M. Porsch Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology Cardiovasc Intervent Radiol 35 2012 921 926
18. P.J. Hosein, A. Echenique, and A. Loaiza-Bonilla Percutaneous irreversible electroporation for the treatment of colorectal cancer liver metastases with a proposal for a new response evaluation system J Vasc Interv Radiol 25 1233-9 2014 e2
19. H.J. Scheffer, and K. Nielsen de Jong MC, et al. Irreversible electroporation for nonthermal tumor ablation in the clinical setting: a systematic review of safety and efficacy J Vasc Interv Radiol 25 2014 997 1011
20. K.R. Thomson, W. Cheung, and S.J. Ellis Investigation of the safety of irreversible electroporation in humans J Vasc Interv Radiol 22 2011 611 621
21. R. Cannon, S. Ellis, D. Hayes, G. Narayanan, and R.C. Martin 2nd Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures J Surg Oncol 107 2013 544 549
22. T.P. Kingham, A.M. Karkar, and M.I. D'Angelica Ablation of perivascular hepatic malignant tumors with irreversible electroporation J Am Coll Surg 215 2012 379 387
23. R.C. Martin, P. Philips, S. Ellis, D. Hayes, and S. Bagla Irreversible electroporation of unresectable soft tissue tumors with vascular invasion: effective palliation BMC Cancer 14 2014 540
24. P. Philips, D. Hays, and R.C. Martin Irreversible electroporation ablation (IRE) of unresectable soft tissue tumors: learning curve evaluation in the first 150 patients treated PloS ONE 8 2013 e76260
25. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 2001 421 430
26. M. Makuuchi, N. Kokudo, and S. Arii Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan Hepatol Res 38 2008 37 51
27. J. Yu, P. Liang, and X.L. Yu Local tumour progression after ultrasound-guided microwave ablation of liver malignancies: risk factors analysis of 2529 tumours Eur Radiol 2015 1119 1126
28. S.L. Ong, G. Gravante, M.S. Metcalfe, A.D. Strickland, A.R. Dennison, and D.M. Lloyd Efficacy and safety of microwave ablation for primary and secondary liver malignancies: a systematic review Eur J Gastroenterol Hepatol 21 2009 599 605
29. M. Ahmed Technology Assessment Committee of the Society of Interventional R. Image-guided tumor ablation: standardization of terminology and reporting criteria-a 10-year update: supplement to the consensus document J Vasc Interv Radiol 25 2014 1706 1708
30. M. Dollinger, E.M. Jung, and L. Beyer Irreversible Electroporation Ablation of Malignant Hepatic Tumors: Subacute and Follow-up CT Appearance of Ablation Zones J Vasc Interv Radiol 25 2014 1589 1594
31. E.W. Lee, S. Thai, and S.T. Kee Irreversible electroporation: a novel image-guided cancer therapy Gut and liver 4 Suppl 1 2010 S99 S104
32. M.T. Silk, T. Wimmer, and K.S. Lee Percutaneous ablation of peribiliary tumors with irreversible electroporation J Vasc Interv Radiol 25 2014 112 118
33. P. Wiggermann, R. Puls, and A. Vasilj Thermal ablation of unresectable liver tumors: factors associated with partial ablation and the impact on long-term survival Med Sci Monit 18 2012 CR88 CR92
34. S.M. Lobo, K.S. Afzal, M. Ahmed, J.B. Kruskal, R.E. Lenkinski, and S.N. Goldberg Radiofrequency ablation: modeling the enhanced temperature response to adjuvant NaCl pretreatment Radiology 230 2004 175 182
35. E. Ben-David, M. Ahmed, and M. Faroja Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties Radiology 269 2013 738 747
36. A.P. O'Rourke, M. Lazebnik, and J.M. Bertram Dielectric properties of human normal, malignant and cirrhotic liver tissue: in vivo and ex vivo measurements from 0.5 to 20 GHz using a precision open-ended coaxial probe Phys Med Biol 52 2007 4707 4719
37. S.R. Smith, K.R. Foster, and G.L. Wolf Dielectric properties of VX-2 carcinoma versus normal liver tissue IEEE Trans Biomed Eng 33 1986 522 524
38. P.R. Stauffer, F. Rossetto, M. Prakash, D.G. Neuman, and T. Lee Phantom and animal tissues for modelling the electrical properties of human liver Int J Hyperthermia 19 2003 89 101
39. S. Laufer, A. Ivorra, V.E. Reuter, B. Rubinsky, and S.B. Solomon Electrical impedance characterization of normal and cancerous human hepatic tissue Physiol Meas 31 2010 995 1009